Search Results

DW-5LBT projected sales volume exceeding initial estimates prompts renegotiation of contract terms; preparations for H-1337 Japan P3 ramp up through partnership with Senju Pharmaceutical

D. Western Therapeutics Institute, Inc. 2Q Earnings Call Flash

Tackling the Loss Ratio through "Prevention" Rather than Rate Hikes — Leveraging 1.4 Million Policies and Advanced Veterinary Medicine to Build the Next Earnings Foundation for Pet Insurance

Anicom Holdings, Inc. Interview Report

Tegoprazan US P3 shows +19.6pt superiority in severe EE healing rate; Lazarus out-licensing reactivates dormant assets; three-tier framework drives value visibility

RaQualia Pharma Inc. 2Q Earnings Call Flash

Recovery in sales productivity and onboarding of 23 FY26 new graduates as catalysts for accelerated growth, with business portfolio restructuring driving the shift toward a profit-oriented model

Mirai Works Inc. 3Q Earnings Call Flash

Launch of KIBIT AI Biology Lab and commercialization of bio-simulation highlighted; next catalysts are securing at least one US deal within the fiscal year and progress on out-licensing pipeline

FRONTEO, Inc. Q1 Earnings Call Flash

Revenue Growth Driven By AI Drug Discovery and Alnetz, But Operating Loss Widens. Full-Year Operating Income of JPY 300M Is Back-End Loaded; AI Drug Discovery Out-Licensing Is The Key

FRONTEO 1Q Earnings Flash

AI DC business accounts for 85% of revenue, driving record-high 1Q revenue of JPY 6.174B; crypto asset valuation losses weigh on recurring profit while progress toward full-year guidance is assessed

eole Inc. 1Q Earnings Flash

Tegoprazan royalty income continues to expand at +14.4% YoY; structure geared toward achieving full-year profitability via milestone recognition in H2

RaQualia Pharma Inc. 2Q Earnings Flash

Record standalone 3Q revenue driven in part by Itochu synergies; 4Q will test whether upfront investment pays off

Tsuji Hongo IT Consulting Co., Ltd. 3Q Earnings Flash

On an effectively standalone basis, 1H revenue rose +42.1% and the company swung to an operating profit. Both AI Products and AI Solutions delivered top-line growth.

Hmcomm 2Q (Interim) Earnings Flash